PLM DFx Risk Intelligence
Design risk surfaced early — traced from concept to production release.
The NovaPulse P-300 Infusion Pump is 47 days from design lock. 10 risk signals have surfaced across 7 subsystems — a critical CTQ traceability gap blocking IEC 62304 verification, an unvalidated CAPA transfer from the P-200 platform, and a roller pin material change with production-scale validation incomplete. 9 suppliers are in qualification, 5 are single-source. The DFX readiness scorecard shows 72% — not ready for design lock. Every design decision must be governed, traced, and audit-ready across 6 DFX pillars.
The Scenario
The countdown. The NovaPulse P-300 Large-Volume Infusion Pump System is 47 days from design lock. Pilot build starts July 15. Design validation in August. Production launch target: January 15, 2027. The design verification gate is open, 9 suppliers are in qualification, and the regulatory path — 510(k) premarket notification under IEC 60601-1, IEC 60601-2-24, IEC 62304, and ISO 14971 — demands full traceability from user needs to V&V protocols. There is no room for risk signals that transfer silently into production.
The NPI risk scan fires. The system scans the full quality history of the P-100 (12,400 field units, 48M field hours) and P-200 (8,200 field units, 22M field hours) platforms — NCRs, CAPAs, field complaints, SCAR records, PPAP records, and FMEA entries — matching each artifact to the P-300 design by subsystem, component, failure mode, and semantic similarity. 10 risk signals surface. Three are blocking.
The risks that matter:
- DFX-RISK-003 (Critical, P×I×C: 100) — Three Critical-to-Quality characteristics on the Electronic Control Unit — touchscreen response time (CTQ-ECU-003), alarm latency (CTQ-ECU-005), and drug library accuracy (CTQ-ECU-007) — have no linked verification protocols. IEC 62304 Class C software items controlling drug delivery require full V&V. The requirements cascade shows 12 orphaned requirements and 7 drifted requirements. Design verification exit is blocked.
- DFX-RISK-001 (Elevated, P×I×C: 60) — CAPA-2024-0012 addressed cassette seal tolerance failures on the P-200, but the P-300 reuses the same seal geometry with specs tightened by 15%. The corrective action has not been validated at the tighter specification. Field complaint FC-2023-0101 documents seal leak under thermal cycling — 75% similarity to the P-300 design. NCR recurrence correlates with mold cavity B batches (cavities 3, 7). Hazard: fluid path leak → patient under-delivery of medication.
- DFX-RISK-005 (Elevated, P×I×C: 48) — The roller pin material change from 440C SS to 316L SS with DLC coating was driven by CAPA-2024-0087 (pitting corrosion at 2,800 hours). Bench validation shows no pitting at 1,000 hours. But DLC adhesion under repeated autoclave cycles has not been validated beyond 500 cycles — and published literature shows DLC adhesion degrades at >300 cycles on some substrates. The 500-cycle autoclave test (VP-FCM-DLC-001) is defined but not executed. Critical path item before design lock.
Seven more signals round out the landscape — tolerance stack yield below target at the seal groove (DFX-RISK-002, P×I×C: 64), supplier SCAR recurrence on motor shaft concentricity (DFX-RISK-004, P×I×C: 36), battery thermal event with single-fault safety risk (DFX-RISK-006, P×I×C: 40), Wi-Fi EMC immunity untested at hospital-level 10 V/m (DFX-RISK-007), OTA cybersecurity validation pending (DFX-RISK-008), IV pole clamp unproven at production scale (DFX-RISK-009), and battery supplier sub-tier material control gap (DFX-RISK-010).
Evidence assembly — 6 source documents, 58 artifacts, seconds. Each artifact is classified by certainty tier:
- Fact (~98% confidence) — direct evidence: NCR-2023-0145, CAPA-2024-0087, calibration records
- Derived (~87%) — multi-source synthesis: tolerance stack Monte Carlo, FMEA RPN computations
- Hypothesis (~65%) — supported inference: CAPA transfer applicability, DLC lifecycle projection
- Conjecture (~50%) — weak signal: sub-tier material batch variation risk, field EMC exposure estimate
AI-guided P×I×C assessment — 5-stage reasoning chain. For each risk signal, the DFX agent executes a multi-stage analysis. On DFX-RISK-001, the agent (1) retrieves CAPA-2024-0012 and 4 linked NCRs spanning 2022–2024 from TrackWise, (2) cross-references DFMEA-003 (Severity 8, Occurrence 4, Detection 5, RPN 160) and tolerance stack TS-001, (3) runs semantic similarity across field complaints and discovers a complaint cluster correlated with mold cavity B batches, (4) computes P×I×C with evidence-backed scoring and ISO 14971 hazard assessment, and (5) generates the gap analysis — CAPA effectiveness at P-300 tighter spec is unvalidated; no thermal cycling test data at P-300 spec limits.
DFX readiness — 6 pillars, 7 subsystems, scored. The scorecard reveals the composite picture:
- DFM (Manufacturability): 72 — cassette seal groove Cpk at 1.12 vs. 1.33 target; molding scrap rate 4.2% vs. 2.0% target at MedPlast Solutions
- DFQ (Quality): 65 — 3 unverified CTQs, 12 orphaned requirements, 7 drifted requirements; FMEA RPN reduction at 60% (8 of 20 actions complete)
- DFR (Reliability): 78 — DLC coating life data limited to 3,000 hrs vs. 5,000-hr target; EPDM gasket compression set data unavailable
- DFC (Cost): 81 — unit cost at $512 vs. $485 target (+5.6%), driven by 316L+DLC material change (+$13) and RF shielding (+$3)
- DFS (Serviceability): 58 — lowest pillar, red status — field-replaceable unit identification incomplete, no diagnostic capability for Wi-Fi troubleshooting, service documentation not started
- DFSC (Supply Chain): 69 — 5 of 9 suppliers single-source; MotorTech Asia with open SCARs and Cpk 1.08; CommChip Taiwan with 14-week lead time and 82% OTIF
Overall DFX readiness: 72%. Not ready for design lock. Improved from P-200 baseline of 62 at the same phase — but DFS and DFSC are lagging.
Supply chain exposure — 9 suppliers, 5 single-source.
- MotorTech Asia (roller assembly, drive motor) — quality score 72/100, SCAR-2024-0008 open for shaft concentricity TIR (8% reject rate on lot MTA-2024-0892), Cpk 1.08 vs. 1.33 target, prior SCAR recurrence within 6 months of closure, audit finding for missing in-process SPC
- MedPlast Solutions (cassette body, seal gasket) — PPAP conditionally approved, seal groove Cpk at 1.15 vs. 1.33 target, 90-day improvement plan in progress, scrap rate 6.2% linked to mold gate location
- BatteryPro China (Li-Ion battery pack) — single-source, audit finding: no incoming inspection on lithium cathode material from sub-tier supplier, supply agreement lacks change notification clause
Requirements traceability — 264 requirements, 12 orphaned, 7 drifted. The cascade maps 47 user needs through 128 system requirements through 89 subsystem requirements to design inputs to V&V protocols. The system flags: UN-006 specifies HL7/FHIR interface for EMR data transmission, but SR-007 only covers Wi-Fi connectivity — protocol compliance requirement missing, safety/regulatory drift. UN-011 (field serviceability) has no system requirement linked at all. SR-011 (roller pin corrosion resistance) was added by the design team without tracing to a customer need. Three unverified CTQs — drug library accuracy, alarm latency, and roller pin corrosion resistance — each require verification protocol assignment before design lock.
Six-stage mitigation workflow. Each risk moves through a governed lifecycle — detection, confirmation, P×I×C analysis with AI-guided reasoning, mitigation planning with assigned owners, approval gates, and closure with evidence linkage at every stage. Sarah Chen (Sr. Design Engineer), Raj Patel (Software/UI Lead), Marcus Johnson (Manufacturing Lead), and Dr. Amara Osei (Quality/Clinical Lead) each own mitigation actions on their respective subsystems.
Trust receipts capture every design decision. 15 governance records preserve the full lineage. DFX-TR-2026-0042: Sarah Chen approves 316L SS + DLC coating for roller pins — alternatives considered (440C SS rejected for corrosion, ZrO2 ceramic rejected for 3.2x cost and brittle fracture risk), evidence cited (NCR-2023-0145, CAPA-2024-0087), assumptions documented (DLC adhesion not validated beyond 500 autoclave cycles), downstream implications (add SPC on coating thickness 2.0±0.3 µm, qualify CoatingTech LLC, add roller pin wear to DVT protocol, evaluate maintenance interval change from 4,000 to 3,500 hours). When the auditor asks “why DLC coating?” — the answer is DFX-TR-2026-0042, with full lineage.
Eight adjacent workflows fire from a single risk signal assessment — design review request with engineering and quality reviewers, CAPA candidate initiation, supplier quality audit scheduling, tolerance stack reassessment with Monte Carlo re-run, verification protocol additions, design verification gate hold, DVT protocol amendments, and supply agreement updates with sub-tier disclosure requirements.
Assessment: 10 risk signals triaged across 7 subsystems and 6 DFX pillars. 3 critical mitigations initiated. 15 design decisions governed with full lineage. DFX readiness: 72%. Design lock: 47 days. Confidence: 89%.
The Problem
Design risk discovered too late. Most organizations find design risk after transfer to manufacturing, after first production runs, after the first field complaint. CAPA-2024-0012 sits in the QMS — it fixed the cassette seal tolerance on the P-200 — but nobody checks whether the same failure mode carries forward when the P-300 tightens the spec by 15%. A CTQ is defined in the user needs — touchscreen response time, alarm latency, drug library accuracy — but the verification protocol is never linked. The roller pin material change is approved based on bench corrosion data — but the 500-cycle autoclave validation is deferred, and the published literature warning about DLC adhesion degradation goes undiscovered. The risks were knowable. They just weren’t surfaced.
DFX assessments in silos. Design-for-manufacturability lives with manufacturing engineering. Design-for-reliability lives with the reliability team. Design-for-quality lives with QA. Design-for-serviceability lives with field service — if it lives anywhere at all. Each function runs its assessment with its own tools and its own timeline. The composite picture — DFS at 58% (red), DFQ at 65% (yellow), 5 of 9 suppliers single-source — doesn’t exist until someone builds a PowerPoint the week before the gate review. By then, the 47 days to design lock have become 12, and the options have narrowed to accept risk or slip the schedule.
Decisions without lineage. The decision to switch from 440C SS to 316L SS with DLC coating was the right call — but the rationale, the alternatives considered (ceramic rollers at 3.2x cost), the assumptions (DLC adhesion beyond 500 cycles), and the downstream implications (new supplier qualification, SPC on coating thickness, maintenance interval change) live in email threads and meeting notes. When the auditor asks why the material was changed, the team reconstructs from fragments. When the field service engineer asks what maintenance interval to use, there is no governed answer. Requirements drift from user needs to V&V protocols without traceability — UN-006 specifies HL7/FHIR, but SR-007 only covers Wi-Fi connectivity. The cost is not just rework. It is delayed launches, 483 observations, and field failures that trace back to risks that were knowable but never governed.
Who This Is For
Design engineering leaders, quality assurance teams, and regulatory affairs professionals in medical device, pharmaceutical, and industrial manufacturing who need to surface and govern design risk before design freeze — not after.
What You’ll Experience
- NPI Semantic Risk Scan — scan the full quality history of prior product families (P-100: 12,400 units, 48M field hours; P-200: 8,200 units, 22M field hours) to surface NCRs, CAPAs, field complaints, SCAR records, PPAP records, and FMEA entries relevant to the current design — matched by component, subsystem, failure mode, and semantic similarity, filterable by severity, subsystem, and document type
- P×I×C Risk Assessment with AI-Guided Reasoning — every risk signal scored on Probability × Impact × Certainty through a multi-stage agent reasoning chain: evidence retrieval from QMS, cross-reference analysis against DFMEA and tolerance data, field signal semantic similarity scan, ISO 14971 hazard assessment, and gap analysis with citation generation — not subjective severity ratings, but calibrated scores with transparent evidence basis and uncertainty radius
- 6-Pillar DFX Readiness Scorecard — composite readiness scoring across DFM, DFQ, DFR, DFC, DFS, and DFSC with per-subsystem health grids (7 subsystems color-coded by score), trend tracking against prior programs (P-200 baseline: 62 → P-300 current: 72), cost impact analysis ($512 vs. $485 target with driver breakdown), and gap analysis targeting the lowest-scoring pillars
- 6-Stage Risk Mitigation Workflow — governed lifecycle from detection through confirmation, P×I×C analysis, mitigation planning with assigned owners and due dates, approval gates, and closure — each stage with evidence linkage, and adjacent workflow triggers firing automatically (design review requests, CAPA candidates, supplier audits, gate holds, DVT protocol amendments)
- Requirements-Cascade Traceability — automated mapping from 47 user needs through 128 system requirements through 89 subsystem requirements to design inputs to V&V protocols — with orphaned requirements (no downstream trace), drifted requirements (parent/child semantic mismatch), and unverified CTQs flagged before they become audit findings or regulatory blockers
- Trust Receipts — audit-ready governance records for every design decision: the decision itself, the reviewer (name and role), alternatives considered with selection/rejection rationale, evidence cited with document IDs, assumptions documented, unresolved gaps identified, and downstream implications traced to process control, verification, supplier, and lifecycle actions — 15 lifecycle decisions preserved with full lineage
- Subsystem Architecture Map — 7 subsystems (FCM, FPC, ECU, PWR, ALM, WCM, HSG), 38 components, 9 suppliers mapped with single-source risk flags (5 of 9), open SCAR tracking with recurrence pattern detection, Cpk monitoring across the supply base, lead time visibility (6–14 weeks), and OTIF performance tracking
- DFX Copilot — AI-guided reasoning that answers design risk questions with multi-stage evidence discovery and citation: “What prior failures are relevant to the cassette seal design?”, “Which CTQs lack verification linkage?”, “What tolerance risks exist in the flow control module?”, “Show me all single-source suppliers with open quality issues” — each response traces through evidence retrieval, cross-reference analysis, and gap identification
- Evidence & Collateral Browser — full library of 58 extracted artifacts from 6 source document types (NCRs, CAPAs, field complaints, SCARs, PPAPs, FMEA entries), each linked to risk signals, trust receipts, and requirements — searchable by subsystem, risk domain, document type, certainty tier, and similarity score
- Risk Heatmap & P×I×C Scatter Plot — active mitigation workflows with priority-based visualization, P×I×C scatter plot (probability vs. impact, bubble size = certainty, color = risk band), scoring bands (Critical ≥91, High 61–90, Elevated 36–60, Moderate 16–35, Low ≤15), and progress tracking against the design lock countdown
- Command Center Dashboard — program-level view with DFX readiness gauge (animated), risk signal summary by status and severity, pillar coverage donut chart, subsystem health grid with top issues per subsystem, recent trust receipts timeline, cost impact summary with variance drivers, milestone timeline with design lock countdown, and quick-action navigation to risk backlog, NPI scan, decision log, scorecard, traceability status, and copilot